Literature DB >> 17307276

Onychomycosis: diagnosis and definition of cure.

Richard K Scher1, Amir Tavakkol, Bárdur Sigurgeirsson, Roderick J Hay, Warren S Joseph, Antonella Tosti, Philip Fleckman, Mahmoud Ghannoum, David G Armstrong, Bryan C Markinson, Boni E Elewski.   

Abstract

Until now, there has been no agreement on criteria defining resolution of onychomycosis. Most published reports use clinical and mycological cure, which comprises a completely normal-appearing nail plate, and negative nail culture and microscopy results, as the end point for defining success of therapeutic intervention. Reported here is the definition of onychomycosis, which delineates both primary and secondary criteria for diagnosis of onychomycosis and identifies clinical and laboratory parameters to define a resolved fungal nail infection. Onychomycosis cure is defined by the absence of clinical signs or the presence of negative nail culture and/or microscopy results with one or more of the following minor clinical signs: (1) minimal distal subungual hyperkeratosis; and (2) nail-plate thickening. Clinical signs indicative of persistent onychomycosis at the end of the observation period include (1) white/yellow or orange/brown streaks or patches in or beneath the nail plate; and (2) lateral onycholysis with subungual debris. Although nail appearance will usually continue to improve after cessation of therapy, the nails may have a persistent abnormal appearance even in cases where treatment has been effective.

Entities:  

Mesh:

Year:  2007        PMID: 17307276     DOI: 10.1016/j.jaad.2006.12.019

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

Review 1.  Skin conditions in figure skaters, ice-hockey players and speed skaters: part II - cold-induced, infectious and inflammatory dermatoses.

Authors:  Brook E Tlougan; Anthony J Mancini; Jenny A Mandell; David E Cohen; Miguel R Sanchez
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

Review 2.  Topical Treatment for Onychomycosis: Is it More Effective than the Clinical Data Suggests?

Authors:  Boni E Elewski; Tracey C Vlahovic; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2016-11-01

Review 3.  Oral antifungal medication for toenail onychomycosis.

Authors:  Sanne Kreijkamp-Kaspers; Kate Hawke; Linda Guo; George Kerin; Sally Em Bell-Syer; Parker Magin; Sophie V Bell-Syer; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2017-07-14

Review 4.  Variability in Systemic Treatment Efficacy for Onychomycosis: Information That Clinical Studies Do Not Impart to the Office Dermatologist.

Authors:  Avner Shemer; Ralph Daniel; Dimitris Rigopoulos; Renata Farhi; Meir Babaev
Journal:  Skin Appendage Disord       Date:  2017-10-26

Review 5.  A hand surgeon's guide to common onychodystrophies.

Authors:  John R Fowler; Elisha Stern; Joseph C English; Robert J Goitz
Journal:  Hand (N Y)       Date:  2014-03

6.  Toenail onychomycosis in a Portuguese geriatric population.

Authors:  N Dias; C Santos; M Portela; N Lima
Journal:  Mycopathologia       Date:  2011-03-02       Impact factor: 2.574

7.  Safety and tolerability of luliconazole solution 10-percent in patients with moderate to severe distal subungual onychomycosis.

Authors:  T Jones; A Tavakkol
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

Review 8.  Network Meta-Analysis of Onychomycosis Treatments.

Authors:  Aditya K Gupta; Deanne Daigle; Kelly A Foley
Journal:  Skin Appendage Disord       Date:  2015-06-26

Review 9.  Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients?

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-08-01

10.  Human dectin-1 deficiency and mucocutaneous fungal infections.

Authors:  Bart Ferwerda; Gerben Ferwerda; Theo S Plantinga; Janet A Willment; Annemiek B van Spriel; Hanka Venselaar; Clara C Elbers; Melissa D Johnson; Alessandra Cambi; Cristal Huysamen; Liesbeth Jacobs; Trees Jansen; Karlijn Verheijen; Laury Masthoff; Servaas A Morré; Gert Vriend; David L Williams; John R Perfect; Leo A B Joosten; Cisca Wijmenga; Jos W M van der Meer; Gosse J Adema; Bart Jan Kullberg; Gordon D Brown; Mihai G Netea
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.